468 related articles for article (PubMed ID: 18078774)
1. Mechanism whereby nitric oxide (NO) infused chronically intrauterine in ewes is antiluteolytic rather than being luteolytic.
Weems YS; Lennon E; Uchima T; Raney A; Goto K; Ong A; Zaleski H; Weems CW
Prostaglandins Other Lipid Mediat; 2008 Feb; 85(1-2):33-41. PubMed ID: 18078774
[TBL] [Abstract][Full Text] [Related]
2. Is nitric oxide luteolytic or antiluteolytic?
Weems YS; Lennon E; Uchima T; Raney A; Goto K; Ong A; Zaleski H; Weems CW
Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):129-38. PubMed ID: 16303611
[TBL] [Abstract][Full Text] [Related]
3. Is endothelin-1 luteolytic or antiluteolytic in ewes?
Weems YS; Johnson D; Uchima T; Raney A; Lennon E; Goto K; Bowers G; Saldana J; Pang J; Randel RD; Weems CW
Prostaglandins Other Lipid Mediat; 2009 Dec; 90(3-4):63-8. PubMed ID: 19723588
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E1 (PGE1), but not prostaglandin E2 (PGE2), alters luteal and endometrial luteinizing hormone (LH) occupied and unoccupied LH receptors and mRNA for LH receptors in ovine luteal tissue to prevent luteolysis.
Weems YS; Nett TM; Rispoli LA; Davis TL; Johnson DL; Uchima T; Raney A; Lennon E; Pang J; Harbert T; Bowers G; Goto K; Ong A; Tsutahara N; Randel RD; Weems CW
Prostaglandins Other Lipid Mediat; 2010 Feb; 91(1-2):42-50. PubMed ID: 20060488
[TBL] [Abstract][Full Text] [Related]
5. In vivo progestin treatments inhibit nitric oxide and endothelin-1-induced bovine endometrial prostaglandin (PG) E (PGE) secretion in vitro.
Weems YS; Randel RD; Tatman S; Lewis AW; Neuendorff DA; Weems CW
Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):264-78. PubMed ID: 16303621
[TBL] [Abstract][Full Text] [Related]
6. What regulates placental steroidogenesis in 90-day pregnant ewes?
Weems YS; Kim L; Tsuda V; Yin C; Weems CW
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888
[TBL] [Abstract][Full Text] [Related]
7. Effect of luteinizing hormone (LH), pregnancy-specific protein B (PSPB), or arachidonic acid (AA) on secretion of progesterone and prostaglandins (PG) E (PGE; PGE(1) and PGE(2)) and F(2alpha) (PGF(2alpha)) by ovine corpora lutea of the estrous cycle or pregnancy in vitro.
Weems YS; Kim L; Humphreys V; Tsuda V; Blankfein R; Wong A; Weems CW
Prostaglandins Other Lipid Mediat; 2007 Nov; 84(3-4):163-73. PubMed ID: 17991618
[TBL] [Abstract][Full Text] [Related]
8. Effects of estrous synchronization on response to nitric oxide donors, nitric oxide synthase inhibitors, and endothelin-1 in vitro.
Weems YS; Randel RD; Tatman S; Lewis AW; Neuendorff DA; Weems CW
Prostaglandins Other Lipid Mediat; 2004 Oct; 74(1-4):45-59. PubMed ID: 15560115
[TBL] [Abstract][Full Text] [Related]
9. Administration of a nitric oxide synthase inhibitor counteracts prostaglandin F2-induced luteolysis in cattle.
Skarzynski DJ; Jaroszewski JJ; Bah MM; Deptula KM; Barszczewska B; Gawronska B; Hansel W
Biol Reprod; 2003 May; 68(5):1674-81. PubMed ID: 12606417
[TBL] [Abstract][Full Text] [Related]
10. Effects of endocannabinoid 1 and 2 (CB1; CB2) receptor agonists on luteal weight, circulating progesterone, luteal mRNA for luteinizing hormone (LH) receptors, and luteal unoccupied and occupied receptors for LH in vivo in ewes.
Tsutahara NM; Weems YS; Arreguin-Arevalo JA; Nett TM; LaPorte ME; Uchida J; Pang J; McBride T; Randel RD; Weems CW
Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):17-24. PubMed ID: 21109016
[TBL] [Abstract][Full Text] [Related]
11. In vivo intra-luteal implants of prostaglandin (PG) E(1) or E(2) (PGE(1), PGE(2)) prevent luteolysis in cows. I. Luteal weight, circulating progesterone, mRNA for luteal luteinizing hormone (LH) receptor, and occupied and unoccupied luteal receptors for LH.
Weems YS; Arreguin-Arevalo JA; Nett TM; Vann RC; Ford SP; Bridges PJ; Welsh TH; Lewis AW; Neuendorff DA; Randel RD; Weems CW
Prostaglandins Other Lipid Mediat; 2011 Aug; 95(1-4):35-44. PubMed ID: 21601649
[TBL] [Abstract][Full Text] [Related]
12. Luteotrophic and luteolytic effects of nitric oxide in sheep are dose-dependent in vivo.
Keator CS; Schreiber DT; Hoagland TA; McCracken JA
Domest Anim Endocrinol; 2008 Jul; 35(1):74-80. PubMed ID: 18448306
[TBL] [Abstract][Full Text] [Related]
13. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue.
Weems YS; Bridges PJ; Jeoung M; Arreguin-Arevalo JA; Nett TM; Vann RC; Ford SP; Lewis AW; Neuendorff DA; Welsh TH; Randel RD; Weems CW
Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):60-5. PubMed ID: 22120546
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E1 or E2 inhibits an oxytocin-induced premature luteolysis in ewes when oxytocin is given early in the estrous cycle.
Weems YS; Pang J; Raney A; Uchima T; Lennon E; Johnson D; Nett TM; Randel RD; Weems CW
Theriogenology; 2014 Aug; 82(3):440-6. PubMed ID: 24908337
[TBL] [Abstract][Full Text] [Related]
15. Effects of prostaglandin E and F receptor agonists in vivo on luteal function in ewes.
Weems YS; Nett TM; Rispoli LA; Davis TL; Johnson DL; Uchima T; Raney A; Lennon E; Harbert T; Bowers G; Tsutahara N; Randel RD; Weems CW
Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):67-72. PubMed ID: 20381634
[TBL] [Abstract][Full Text] [Related]
16. Infusion of exogenous tumor necrosis factor dose dependently alters the length of the luteal phase in cattle: differential responses to treatment with indomethacin and L-NAME, a nitric oxide synthase inhibitor.
Skarzynski DJ; Woclawek-Potocka I; Korzekwa A; Bah MM; Piotrowska K; Barszczewska B; Okuda K
Biol Reprod; 2007 Apr; 76(4):619-27. PubMed ID: 17192516
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E1 or E2 (PGE1, PGE2) prevents premature luteolysis induced by progesterone given early in the estrous cycle in ewes.
Weems YS; Raney A; Pang J; Uchima T; Lennon E; Johnson D; Nett TM; Randel RD; Weems CW
Theriogenology; 2013 Sep; 80(5):507-12. PubMed ID: 23800694
[TBL] [Abstract][Full Text] [Related]
18. Effects of LPA2R, LPA3R, or EP4R agonists on luteal or endometrial function in vivo or in vitro and sirtuin or EP1R, EP2R, EP3R or EP4R agonists on endometrial secretion of PGE and PGF
LaPorte ME; Weems YS; Arreguin-Arevalo A; Nett TM; Tsutahara N; Sy T; Haberman J; Chon M; Randel RD; Weems CW
Theriogenology; 2017 Jun; 95():8-17. PubMed ID: 28460684
[TBL] [Abstract][Full Text] [Related]
19. Reconsideration of the proposed luteotropic and luteoprotective actions of ovine placental lactogen in sheep: in vivo and in vitro studies.
Al-Gubory KH; Camous S; Germain G; Bolifraud P; Nicole A; Ceballos-Picot I
J Endocrinol; 2006 Mar; 188(3):559-68. PubMed ID: 16522735
[TBL] [Abstract][Full Text] [Related]
20. Effect of PGF2alpha, indomethacin, tamoxifen, or estradiol-17beta on incidence of abortion, progesterone, and pregnancy-specific protein B (PSPB) secretion in 88- to 90-day pregnant sheep.
Bridges PJ; Weems YS; Kim LM; Sasser RG; LeaMaster BR; Vincent DL; Weems CW
Prostaglandins Other Lipid Mediat; 1999 Oct; 58(2-4):113-24. PubMed ID: 10560614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
